| FSLZX | FSMAX | FSLZX / FSMAX | |
| Total Expense Ratio | 0.55 | 0.04 | 1,571% |
| Annual Report Gross Expense Ratio | 0.55 | 0.04 | 1,571% |
| Fund Existence | 9 years | 14 years | - |
| Gain YTD | 4.907 | 6.492 | 76% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.16B | 41.5B | 5% |
| Annual Yield % from dividends | 0.72 | 0.43 | 167% |
| Returns for 1 year | -0.67 | 3.62 | -18% |
| Returns for 3 years | 22.40 | 49.92 | 45% |
| Returns for 5 years | 23.80 | 33.53 | 71% |
| Returns for 10 years | N/A | 94.09 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DRTHX | 21.36 | 0.09 | +0.42% |
| BNY Mellon Sustainable US Eq Fd Z | |||
| WFILX | 58.65 | N/A | N/A |
| Allspring Index A | |||
| MSVOX | 6.34 | N/A | N/A |
| Morgan Stanley Vitality Portfolio R6 | |||
| VSFAX | 24.56 | -0.05 | -0.20% |
| Federated Hermes Clover Small Value A | |||
| JNGLX | 81.77 | -0.17 | -0.21% |
| Janus Henderson Global Life Sciences D | |||